Skip to content

Therapeutic effect of Bu-Shen Jian-Gu formulation in the treatment of diabetic osteoporosis based on the TCM theory of 'Kidney acting on bone producing marrow'

Therapeutic effect of Bu-Shen Jian-Gu formulation in the treatment of diabetic osteoporosis based on the TCM theory of 'Kidney acting on bone producing marrow'

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900024360
Enrollment
Unknown
Registered
2019-07-07
Start date
2019-08-01
Completion date
Unknown
Last updated
2019-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic osteoporosis

Interventions

Sponsors

Gansu Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria of diabetes mellitus and osteoporosis; 2. Aged 18-75 years; 3. Signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Anti-osteoporosis therapy (excluding calcium supplements) was given one month before already; 2. Osteoporosis caused by other metabolic diseases, such as nail fever, parathyroid congestion, Cushing's syndrome and lengthening, Phase use of drugs affecting bone metabolism, such as glucocorticoids, etc. 3. Complicated with severe heart, liver and kidney insufficiency, chronic respiratory diseases and acute coronary syndrome; 4. Patients with acute cerebrovascular accident, hematopoietic disorders and psychiatric diseases; 5. Use hypoglycemic drugs that have definite effects on bone metabolism, such as salivary diketones; 6. Pregnancy, lactation or women intending to conceive in the coming year; 7. Those with active gastrointestinal tract and bleeding tendency; 8. Anaphylaxis to drugs or major components used in the program; 9. Those who are unable to cooperate, such as psychiatric or Alzheimer's patients; 10. In recent months, diabetes mellitus patients with acute metabolic disorders; 11. Those who have a history of alcohol or drug abuse; 12. Reluctant participants.

Design outcomes

Primary

MeasureTime frame
bone density;weight;

Countries

China

Contacts

Public ContactZhang Dong-Peng

Gansu Provincial Hospital of Traditional Chinese Medicine

zdp2009163@163.com+86 18919832156

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026